Drug Database
AN

anthrax vaccine (GC 1109 / GC1109)

✓ Approved

GC Biopharma · · 重组蛋白

什么是 anthrax vaccine?

anthrax vaccine 是一种重组蛋白,由GC Biopharma研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名GC 1109, GC1109
公司GC Biopharma
药物类别重组蛋白, 疫苗
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

作用机制

分子靶点

anthrax vaccine 作用于 1 个分子靶点:

()
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

anthrax vaccine 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsAnthrax✓ Approved

相关研究文献

PubMedVeterinary medicine international2026-10-26

Participatory Epidemiology of Major Camel Diseases and Their Management in Somalia: The Case of Banadir and Lower Shabelle Regions.

Salah Omar O, Sh Hassan Yasin Y, Yusuf Mohamed M, AbdiNB Hassan H

This study investigates major camel diseases, their community-perceived epidemiological characteristics, and management practices in the Banadir and Lower Shabelle regions of Somalia. Data were collected from 17 key informants through semistructured interviews and from 18 participants across three focus group discussions (FGDs). Semistructured interviews captured key camel diseases, their local names, disease impacts, coping mechanisms, and locally used disease management approaches, while FGDs were used to conduct participatory exercises to rank and characterize diseases based on severity and clinical signs. Kendall's W was used to assess consensus among participants, revealing the strength of the agreement across groups. Ten diseases were most frequently reported, including trypanosomosis, mastitis, pneumonia, ringworm, camelpox, mange, tetanus, wry neck, parasite infection, and anthrax. For disease management practices, about 15 out of 17 respondents reported using both modern medicines and traditional practices such as burning, administering Dobera glabra seeds, and applying camel hump ghee. In addition, 13 out of 17 informants indicated that farmers do not conduct regular animal health checkups. Preventive measures included isolation, relocation, and recitation of the Holy Quran. Regarding veterinary consultation, 10 out of 17 respondents reported poor veterinary consultation, citing limited awareness and poor accessibility as potential causes. Of the eight diseases assessed by pairwise ranking, farmers rated anthrax (Kud) as the most severe (mean 6.67 ± 0.58 out of 7), followed by tetanus (Taagow, 6.00 ± 1.00), with strong, statistically significant agreement across the focus groups (Kendall's W = 0.849; p = 0.013). Wry neck and trypanosomosis were rated moderately severe, while pneumonia, mange, mastitis, and camelpox scored lowest. Matrix scoring showed strong, statistically significant agreement among the three informant groups across all disease signs (Kendall's W = 0.74-1.00; p < 0.05). The strongest associations were dyspnea and nasal discharge with pneumonia (mean scores 15.00 ± 1.00/20 and 16.67 ± 2.08/20), odor change with trypanosomosis (15.00 ± 3.00/20), and fever with camelpox and trypanosomosis. The findings also revealed clear seasonal variation in camel diseases, with most conditions peaking during the rainy seasons of spring (Gu) and autumn (Dayr). In contrast, trypanosomosis, tetanus, and mange occurred throughout the year, while anthrax was predominantly associated with the dry Jiilaal season. Major challenges reported include limited veterinary services, high treatment costs, and inadequate feed and drug supplies. These findings reflect substantial indigenous knowledge and point to the need for integrated interventions including improved veterinary services, affordable drugs and vaccines, and farmer capacity building to strengthen camel health in the region.

PMID 42928791
阅读全文 →
PubMedCancer discovery2026-10-26

First mRNA Cancer Vaccine Succeeds in Phase III Trial.

Adding the mRNA-based individualized neoantigen vaccine intismeran autogene to the PD-1 inhibitor pembrolizumab following surgery for melanoma reduced the risk of disease recurrence or death by 42%, according to the results of the phase III INTerpath-0001 trial. The data were presented at the ESMO Congress 2026, held October 23-27, in Madrid, Spain.

PMID 42929716
阅读全文 →
PubMedAnimal health research reviews2026-10-26

Innovative vaccine strategies for sustainable control and eradication of peste des petits ruminants virus.

Bello Muhammad Bashir MB, Hameed Sodiq A SA, Abdullahi Adama Musa AM, Lawal Nafi'u N et al.

PMID 42929676
阅读全文 →
PubMedEpidemiologia (Basel, Switzerland)2026-10-26

A Carriage-Structured Model of Meningococcal Meningitis: Backward Bifurcation, Seasonal Recurrence, and the Reach of Conjugate-Vaccine Strategies in the African Meningitis Belt.

Gatyeni Siphokazi Princess SP

Epidemic meningococcal meningitis in the African meningitis belt recurs on two timescales: a sharp annual dry-season peak and irregular multi-annual epidemics five to twelve years apart, whose mechanistic origin remains unsettled. Invasive disease is a rare, dead-end outcome of asymptomatic nasopharyngeal carriage, so susceptible-infectious templates misrepresent community transmission. We ask how carriage structure shapes bifurcation, seasonal recurrence, and the reach of conjugate-vaccine strategies. We formulate a deterministic carriage-structured model in which only carriers transmit, immunity against re-acquisition is leaky, and a conjugate vaccine is imperfect and wanes. We use the Castillo-Chavez-Song centre manifold method, numerical continuation, Floquet and eigenvalue analysis, and scenario simulations of abstract rate- and pulse-type interventions parameterised from published belt ranges. The basic reproduction number R0 is a property of carriage transmission, decoupled to first order from disease incidence. Backward bifurcation at R0=1 is governed by a threshold ε∗ on carriage-blocking immunity; only the untreated fatality hazard and treatment capacity are absent from the local condition. It is impossible without vaccination and, with any positive routine coverage, persists across the plausible coverage range, giving vaccine-induced bistability. Continuation confirms a fold at R0,c≈0.946 (φ=0.12yr-1, weak carriage immunity), but not at baseline immunity. Under seasonal forcing, dynamics converge to a simple annual cycle throughout the region searched; we found no multi-annual recurrence, although damped eigenmodes of the unforced system have periods overlapping the observed interval. Within this deterministic, single-strain model, irregular recurrence likely requires additional structure, with stochastic amplification of damped cycles a natural next step. Whether sustained immunisation eliminates epidemics or merely postpones them may depend on the same carriage-efficacy threshold that governs the bistability result.

PMID 42930328
阅读全文 →
PubMedJournal of virology2026-10-26

Early innate immune signatures correlate with Ad26.COV2.S vaccine immunogenicity and protective efficacy.

Colarusso Alessandro A, Stephenson Kathryn E KE, Collier Ai-Ris Y A-RY, Wegmann Frank F et al.

The innate immune system is rapidly activated following antigen exposure and plays a critical role in shaping the ensuing adaptive immune responses. In this study, we performed bulk RNA sequencing and proteomic profiling in a cohort of 25 rhesus macaques following Ad26.COV2.S immunization to characterize early innate correlates of vaccine immunogenicity and protection. Our results show that innate immune activation occurred as early as day 1 post-vaccination and demonstrated a systemic enrichment of antiviral interferon pathways, cytokine signaling, and activation of innate immune cell signatures. These early transcriptomic signatures correlated positively with humoral and cellular immune responses at 6 weeks following vaccination and correlated inversely with viral loads following SARS-CoV-2 challenge. Similar correlates of immunogenicity were observed in a cohort of 25 adult healthy participants vaccinated with Ad26.COV2.S. Taken together, these findings highlight the importance of early activation of the innate immune responses following Ad26.COV2.S vaccination in shaping the protective adaptive immune response.IMPORTANCEEarly innate immune responses may shape vaccine immunogenicity and protection. We evaluated responses to Ad26.COV2.S vaccination in rhesus macaques and humans and found that day 1 innate immune signatures correlated with subsequent adaptive responses. These findings suggest that early post-vaccination immune programming influences immunogenicity and protective efficacy months later.

PMID 42929544
阅读全文 →
PubMedDiseases (Basel, Switzerland)2026-10-26

Divergent Human Papillomavirus Genotype Spectra in Three Indigenous Communities of Venezuela: Implications for Vaccine Choice and Cervical Screening.

Garcés María Fátima MF, Guzmán Silva Jefferson J, Aranguren Daniel D, Figueira Lina L et al.

Background: Genotype-resolved data on human papillomavirus (HPV) are almost absent for Venezuelan indigenous women. Methods: We studied 260 women from La Guajira (Wayuu, n = 94), Maniapure (Eñepa, n = 141), and Delta Amacuro (Warao, n = 25), processing all self-collected samples with a single real-time PCR assay that resolves 21 genotypes; cytology was available for 144. Results: HPV prevalence was 55.4% (95% CI 49.3-61.3) and high-risk prevalence was 51.2% (95% CI 45.1-57.2), rising from 42.6% in La Guajira to 59.6% in Maniapure and 80.0% in Delta Amacuro (p = 0.001). Nineteen genotypes were detected. HPV-31 was most frequent (15.8%), followed by HPV-16 (11.5%), and each community had its own profile, with HPV-68 and HPV-56 leading in Delta Amacuro. Half of the infected women carried more than one type. Cytology and HPV testing overlapped little: 20 of 78 HPV-positive women with a smear (25.6%) had an abnormal result (κ = 0.056). At least one nonavalent vaccine type was present in 69.4% of infected women, compared with 30.6% for the bivalent vaccine. Conclusions: HPV vaccination is not part of the Venezuelan national program; these data favor the nonavalent formulation, and HPV-based screening would need a feasible triage pathway for the many women who test positive.

PMID 42930011
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多anthrax vaccine